HYDROMORPHONE HCL-BUPIVACAINE HCL-BACLOFEN PF INJECTABLE 21 mL… — Class I drug recall D-0708-2021
Terminated recall by Med Shop Total Care Inc., reported 2021-08-18, distributed in PR, TX. Non-Sterility
| Recall number | D-0708-2021 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Med Shop Total Care Inc., Longview, TX, United States |
| Recall initiated | 2020-10-05 |
| Classified | 2021-08-09 |
| Reported by FDA | 2021-08-18 |
| Terminated | 2023-08-17 |
| Distributed | PR, TX |
| Quantity | 126 ml |
| Reason classes | sterility |
| Expiration dates | 2020-10-29 |
Product
HYDROMORPHONE HCL-BUPIVACAINE HCL-BACLOFEN PF INJECTABLE 21 mL syringes in various strengths: a) 2.5MG-1.25MG-0.5MCG/ML, b) 10MG-5MG-10MCG/ML, c) 2MG-1MG-10MCG/ML, d) 10MG-5MG-10MCG/ML, e) 15MG-5MG-2000MCG/ML, f) 8MG-10MG-400MCG/ML, Rx only, Med Shop Total Care 470 East Loop 281 Longview, TX 75605
Reason for recall
Non-Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0708-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.